Referring to MAPK on the other hand, we could show recently that blockade of DDR1 and MAPK components act synergistically in sensitizing breast cancer cells for doxorubicin and mitoxantrone toxicity upon cell binding to collagen [28,53]. This evidence concerns the gene DDR1 and breast carcinoma.